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PURPOSE. To investigate potential associations of the ICAM-1
gene polymorphisms and Fuchs uveitis in a cohort of Italian
patients.
METHODS. Seventy-one consecutive Italian patients affected by
Fuchs uveitis were observed at the Ocular Immunology Unit,
Arcispedale S. Maria Nuova (Reggio Emilia, Italy) from 2002 to
2008. Two hundred twenty-six healthy Italian blood donors
from the same geographic area were selected as the control
group. All Fuchs uveitis patients and control subjects were
genotyped by polymerase chain reaction (PCR) and allele-
specific oligonucleotide techniques for ICAM-1 polymor-
phisms at codon 241 (exon 4).
RESULTS. The frequency of the ICAM-1 G/R 241 polymorphism
was significantly higher in Fuchs uveitis than in the control
subjects (16.9% vs. 5.8%; P  0.006, Pcorr  0.012; odds ratio,
3.3; 95% confidence interval, 1.4–7.7). No significant associa-
tion between clinical features and ICAM-1 polymorphisms was
found.
CONCLUSIONS. This study demonstrates for the first time that the
ICAM-1 G/R 241 polymorphism may represent a candidate
gene for Fuchs uveitis susceptibility. (Invest Ophthalmol Vis
Sci. 2010;51:4447–4450) DOI:10.1167/iovs.09-4669
Intercellular adhesion molecule-1 (ICAM-1; CD54), a 90-kDamember of the immunoglobulin (Ig) superfamily, is ex-
pressed on the surface of several cell types including leuko-
cytes, endothelial cells, and proliferating intimal smooth mus-
cle cells. Its ligands are the membrane-bound 2-integrin
receptors LFA-1 (CD11a, CD18) and Mac-1 (CD11b, CD18) on
leukocytes, although several other ligands have been de-
scribed.1 ICAM-1 is critical in the firm arrest and transmigration
of leukocytes out of blood vessels and into tissues.2 ICAM-1 is
present on endothelial cells and all leukocytes, where it acts
both as an adhesion2 and a signaling3–6 molecule, and its
expression is enhanced by different cytokines, including tumor
necrosis factor (TNF), interferon-, and interleukin-1. Endothe-
lial expression of ICAM-1 is increased in atherosclerotic and
transplant-associated atherosclerotic tissue and in animal mod-
els of atherosclerosis,7–9 and it has been implicated in the
progression of autoimmune diseases, including rheumatoid ar-
thritis, multiple sclerosis, and type I diabetes.10–13
Several ICAM-1 coding region biallelic polymorphisms have
been described in the human ICAM-1 gene, including those
located in exons 4 and 6, thereby modifying codons 241 and
469, respectively.14 G241R (glycine/arginine) is located within
the third Ig-like domain, shown to be the Mac-1 binding do-
main,15 and therefore is of potential importance during leuko-
cyte transmigration. The hypothesis is that, since the ICAM-1
gene polymorphisms are located in exons and lead to amino
acid substitutions, they could alter ligand binding or the stabil-
ity of the multimeric ICAM-1 on the cell surface and therefore
alter signal transduction. Many studies have described associa-
tions between ICAM-1 polymorphisms and chronic inflamma-
tory disorders, including ulcerative colitis and Crohn’s dis-
ease,16,17 polymyalgia rheumatica,18 type I diabetes,19 multiple
sclerosis,20 chronic allograft vasculopathy,21,22 peripheral oc-
clusive vascular disease,23,24 and myocardial infarction.25 How-
ever, there is no consensus as to which alleles are protective
and which are detrimental. Interpretation of these clinical
associations is hindered by lack of understanding of the func-
tional significance of ICAM-1 polymorphisms.
Fuchs uveitis is a chronic inflammatory eye disease of un-
known etiology that usually presents as a unilateral anterior
uveitis in young adults. It is often characterized by an insidious
onset and is frequently misdiagnosed; complications include
cataract formation and secondary glaucoma. Several theories
have been suggested regarding its etiology, including an immu-
nologic disorder characterized by elevated levels of immuno-
globulin G in aqueous humor of patients26,27 and CD8 cells.28
Recent findings have suggested that an infectious agent such as
Toxoplasma gondii29,30 or Rubella virus31,32 could act as a
trigger of eye inflammation.
ICAM-1 has been shown to play an important role in the
induction and development of inflammation in uveitis in both
in vitro and in vivo animal studies.33–36 La Heij et al.33 found a
significantly increased expression of adhesion molecules in the
iris of patients affected by uveitis, including Fuchs uveitis,
suggesting an immunoregulatory function for adhesion mole-
cules in the pathogenesis of uveitis.
We postulated that the polymorphism of the ICAM-1 gene




The study protocol adhered to the tenets of the Declaration of Helsinki
and was approved by the local institutional review board. Informed
consent was obtained from patients and control subjects before they
were included in the study.
From the 1Ocular Immunology Unit, 2Ophthalmology Unit, 3Rheu-
matology Unit, and 5Molecular Biology Laboratory, Arcispedale S Maria
Nuova Reggio Emilia, Italy; and the 4Institute of Ophthalmology, Univer-
sity of Parma, Parma, Italy.
Submitted for publication September 21, 2009; revised February 2
and March 23, 2010; accepted April 9, 2010.
Disclosure: L. Cimino, None; L. Boiardi, None; R. Aldigeri,
None; B. Casali, None; D. Nicoli, None; E. Farnetti, None; C.
Salvarani, None; D. Cirone, None; L. De Martino, None; A. Pupino,
None; L. Cappuccini, None
Corresponding author: Luca Cimino, Ocular Immunology Unit,
Ophthalmology, Unit, Arcispedale S Maria Nuova Reggio, Viale Risorgi-
mento, 80 Reggio, Emilia, 42123 Italy; l.cimino@libero.it.
Biochemistry and Molecular Biology
Investigative Ophthalmology & Visual Science, September 2010, Vol. 51, No. 9
Copyright © Association for Research in Vision and Ophthalmology 4447
Downloaded from iovs.arvojournals.org on 05/20/2020
From May 2002 to June 2008, 71 consecutive patients with Fuchs
uveitis were examined at the Immunology Ocular Unit, Arcispedale S.
Maria Nuova Hospital (Reggio Emilia, northern Italy). Demographic
data and ocular findings (Table 1) and laboratory tests were recorded
in a computer database.
Details on laterality, chronicity, and ocular signs were included.
Patients with uveitis and associated underlying systemic diseases were
excluded. The study included 226 healthy subjects who were unre-
lated blood donor volunteers.
The diagnosis of Fuchs uveitis was based on the presence of the
following clinical features: unilateral uveitis involving the anterior
segment and the vitreous body, absence of acute symptoms (pain,
photophobia), characteristic Fuchs stellate keratic, sparsely distributed
precipitates, diffuse iris stromal atrophy with or without heterochro-
mia, vitritis, absence of synechiae, and the absence of cystoid macular
edema.37
All the study subjects were Caucasians residing in Italy for at least
one generation. No ethnic differences were present between patients
and control subjects.
Molecular Analysis of the ICAM-1 Polymorphism
Genomic DNA was extracted by phenol-chloroform standard method
from 500 L whole blood collected in edetic acid. To detect the
substitution of arginine for glycine responsible for the ICAM-1 poly-
morphism G/R 241 in exon 4 of the ICAM-1 gene, we developed an
allele-specific polymerase chain reaction (ASPCR) method. We desig-
nated allele-specific primers 5-CGTGGTCTGTTCCCTGGACG-3, 5-
CGTGGTCTGTTCCCTGGACA-3 (nucleotide number 638-657), using
published sequence information on the point mutation of the ICAM-1
gene,38 and common primer 5-GTCGTTGCCATAGGTGACTG-38. As
an internal positive control, an additional primer pair for the glycop-
rotein IIIa gene39 was used in all ASPCRs, with a pair of primers
consisting of an allele-specific primer and a common primer, according
to the method of Bein et al.40 The positive control primer pair ampli-
fied the 247-bp fragment of glycoprotein IIIa gene. The ASPCR was
performed in a total volume of 50 L that contained 0.2 g genomic
DNA, each primer pair consisting of 20 picomoles of allele-specific
primer and 20 picomoles of common primer, 15 picomoles of each
positive control primer, 200 M each dNTP, 10 mM Tris-HCl (pH 8.3),
50 nM KCl, 1.5 mM MgCl2, and 1.5 units of DNA polymerase (Ampli-
Taq; Perkin-Elmer, Waltham, MA). The PCR reaction was performed for
35 cycles, each consisting of a denaturation step at 95°C for 30
seconds, 68°C for 30 seconds, and 72°C for 30 seconds in a PCR system
(GeneAmp PCR System 9600; Perkin Elmer). The amplified PCR prod-
ucts were analyzed by 2% agarose gel electrophoresis followed by
ethidium bromide staining and ultraviolet visualization.
Statistical Analysis
The frequencies of the alleles and genotypes between patient and
control groups were compared by means of 2 test. Odds ratios (ORs)
were calculated together with 95% confidence intervals (CIs). Cor-
rected P values were calculated by multiplying P by the number of
alleles compared (SPSS statistical package; SPSS Inc., Chicago, IL).
Statistical analysis to define population sample size and statistical
power was performed with PAWE software (PAWE version 1.2, Feb-
ruary 2003 written by Derek Gordon assisted by Michael Nothnagel,
Rockefeller University, New York, NY).41–45
RESULTS
The demographic and clinical features of patients are reported
in Table 1. Thirty-nine (55%) patients were male and 32 (45%)
were female. The mean age was 42 years (range, 8–78 years).
Eye findings included stellate keratic precipitates in 53 (75%)
cases, vitritis in 63 (89%), iris atrophy in 65 (91%), and hetero-
chromia in 35 (49%). Fuchs uveitis was mostly unilateral (91%).
Twenty-six (14%) patients presented with cataract and nine
(13%) with glaucoma.
The allele and genotype frequencies of G/R 241 in patients
and controls are reported in Table 2.
Allele R was significantly more frequent in the uveitis pa-
tients than in the control subjects (P  0.001, Pcorr  0.002;
OR, 3.7; 95% CI, 1.7–7.9), and the carriage rate of R241 was
significantly higher in the patients than in the control subjects
(16.9% vs. 5.8%; P  0.006; Pcorr  0.012; OR, 3.3; 95% CI,
1.4–7.7). Furthermore, the distribution of the G/R 241 geno-
TABLE 1. Demographic and Clinical Features of Patients with
Fuchs Uveitis




Mean age in years  SD 42  15 —
Keratic precipitates 53 74.6







TABLE 2. Frequencies of Alleles, Genotypes, and Carriage Rates of ICAM-1 G/R 241 Polymorphism in Fuchs Uveitis Cases and Controls
Fuchs Uveitis
(n  71) Controls (n  226)
P Pcorr OR (95% CI)n % n %
Allele
R 15/142 10.6 14/452 3.1 0.001 0.002 3.7 (1.7–7.9)
G 127/142 89.4 438/452 96.9
Genotype
R/R 03/71 4.2 01/226 0.4 0.005 0.015
R/G 09/71 12.7 12/226 5.3
G/G 59/71 83.1 213/226 94.2
Carriage rate
R/RR/G 12/71 16.9 11/226 5.8 0.006 0.012 3.3 (1.4–7.7)
G/G 59/71 83.1 213/226 94.2
R/R 3/71 4.2 1/226 0.4 0.044 0.088 9.9 (1.0–97.0)
R/GG/G 68/76 95.8 225/226 99.6
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type differed significantly between the patients and control
subjects (P  0.005; Pcorr  0.015).
Sample size and the allele frequencies of the G/R 241
polymorphism provided a statistical power of more than 90%
for genotypic test and more than 95% for allelic test. No
association was found between clinical features and the fre-
quencies of genotypes.
DISCUSSION
Intercellular adhesion molecules play an important role in the
recruitment of specific T lymphocytes from the blood stream
into inflamed tissue. ICAM-1 has been proven to be important
in the induction and development of inflammation in uveitis,
whether or not it is associated with systemic disease, both in
vitro and in vivo animal studies. Furthermore, Whitcup et al.46
reported that serum ICAM-1 levels were higher in patients with
uveitis than in normal control subjects and were significantly
higher in patients with uveitis associated with an underlying
systemic disease than in those without systemic disease. In
contrast, other studies reported that serum ICAM-1 levels in
accompanying systemic disease were similar to those in iso-
lated uveitis.47–49 To date, ICAM polymorphisms, particularly
G/R 241 polymorphism, have been studied in Behçet disease,
polymyalgia rheumatica/giant cell arthritis, and rheumatoid
arthritis.50–52 We hypothesized that G/R 241 polymorphism of
ICAM-1 could be associated with Fuchs uveitis. The molecular
analysis of ICAM-1 gene confirmed that G/R 241 polymorphism
frequency was higher in patients affected by Fuchs uveitis than
in control subjects, confirming that it could represent a risk
factor for this ocular entity.
A recent experimental study on the functional significance
of ICAM-1 polymorphisms, in terms of cell surface expression
of ICAM-1 and leukocyte adhesion to human endothelial cells,
confirmed that the genotype G241/E469 was associated with
greater cell surface expression, leading to greater adhesion of
leukocytes.53 This finding could explain the described associ-
ations of ICAM polymorphisms with chronic inflammatory dis-
ease.
In their study on the correlation between genetic polymor-
phism and circulating soluble ICAM-1 in a healthy population,
Ponthieux et al.54 confirmed a significant association between
R241 allele and lower serum ICAM-1 levels, probably due to the
binding impairment of ICAM-1 to leukocyte integrin Mac-1
protein. We found a significant increase in the R241 allele in
Fuchs uveitis in our population compared with that in the
control subjects, and this increase may explain the chronic
low-grade inflammation response in this disease.
Most Fuchs patients present with minimal anterior chamber
inflammation, and therapy is not required. Symptomatic flare-
ups may require short-term topical corticosteroids. However,
long-term therapy is not indicated. Theoretically, variations of
serum protein levels may be influenced by disease activity,
systemic manifestations or systemic therapy. These fluctuating
influences may explain why our results are different from those
in earlier studies of serum ICAM-1 levels. On the other hand,
disease activity and systemic therapy should not affect gene
polymorphisms, as reported in our study.
To our knowledge, an association between ICAM-1 poly-
morphisms and Fuchs uveitis has never been reported. Since
Fuchs uveitis represents a frequent cause of uveitis in our
region, and the etiology is still unknown, this study could be a
first step in understanding whether this polymorphism repre-
sents a risk factor for this ocular disease.
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